6th Dec 2007 07:00
Summit Corporation PLC06 December 2007 Summit Corporation plc ("Summit plc" or "the Company") SUMMIT PLC APPOINTS PANMURE GORDON AS NOMINATED ADVISER AND BROKER Oxford, UK, 6 December 2007 - Summit Corporation plc (AIM: SUMM), a leading UKbiotechnology company, today announces that it has appointed Panmure Gordon &Co. as its nominated adviser and sole corporate broker with immediate effect. - ENDS - For more information, please contact:Summit plc Steven Lee, PhD, Chief Executive Officer Tel: +44 (0)1235 443951Darren Millington, ACMA, Chief Financial OfficerRichard Pye, PhD, Investor Relations Citigate Dewe RogersonMark Swallow / David Dible / Yvonne Alexander Tel: +44 (0)207 638 9571 Panmure GordonAndrew Burnett / Rakesh Sharma Tel: +44 (0)207 459 3600 About Summit plc Summit plc is a leading UK biotechnology company that discovers and developsproprietary new drugs. The Company's internal drug development programmes areunderpinned by its advanced carbohydrate chemistry and drug screening (chemicalgenomics) technology platforms, which it also provides on a collaborative orfee-for-service basis to the pharmaceutical industry. Summit plc has a broad range of drug discovery programmes in the clinical,pre-clinical and discovery stages of development, which target serious diseaseswith a high unmet medical need. These therapeutic areas include neuro-disorders(neurodegenerative and neuromuscular), anti-infectives, ophthalmic diseases,oncology and regenerative medicines. Summit plc's in-house drug development capabilities combine world-classexpertise in both carbohydrate chemistry with high-volume, high-contentscreening using its proprietary zebrafish and fruitfly technologies (chemicalgenomics). These whole organism screens have the potential to dramaticallydecrease the time and cost of drug discovery and development by delivering datathat are highly predictive of the efficacy and toxicity of potential drugcompounds in humans. The company listed on the AIM market of the London Stock Exchange in October2004 - symbol: SUMM Further information about the company is available at www.summitplc.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SUMM.L